A detailed history of Farallon Capital Management LLC transactions in Insmed Inc stock. As of the latest transaction made, Farallon Capital Management LLC holds 3,000 shares of INSM stock, worth $222,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,000
Previous 568,000 99.47%
Holding current value
$222,270
Previous $38.1 Million 99.42%
% of portfolio
0.0%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $35 Million - $44.6 Million
-565,000 Reduced 99.47%
3,000 $219,000
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $12.5 Million - $39.6 Million
568,000 New
568,000 $38.1 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.